3005

COM:JAFRON

健帆生物科技集团股份有限公司

  • Stock

Last Close

31.30

22/11 07:04

Market Cap

22.44B

Beta: -

Volume Today

7.59M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
25.72M
-
31.17M
21.20%
37.04M
18.83%
44.75M
20.81%
47.86M
6.96%
53.20M
11.15%
76.74M
44.25%
106.49M
38.78%
158.61M
48.94%
272.84M
72.02%
367.06M
34.54%
average payables
6.20M
-
7.83M
26.41%
19.10M
143.75%
24.18M
26.60%
22.80M
5.71%
27.77M
21.82%
31.36M
12.94%
41.52M
32.39%
55.49M
33.63%
94.64M
70.56%
132.07M
39.55%
average receivables
19.49M
-
34.06M
74.75%
58.65M
72.18%
81.34M
38.68%
106.38M
30.78%
143.22M
34.64%
178.26M
24.47%
235.08M
31.87%
326.74M
38.99%
363.61M
11.29%
224.51M
38.26%
book value per share
0.54
-
0.64
19.24%
0.80
25.02%
1.60
100.46%
1.78
10.79%
2.16
21.44%
2.70
25.28%
3.53
30.54%
4.18
18.54%
4.50
7.62%
3.97
11.87%
capex per share
-0.09
-
-0.09
2.00%
-0.09
4.23%
-0.04
55.43%
-0.23
484.87%
-0.22
2.89%
-0.28
26.30%
-0.45
61.25%
-0.67
49.07%
-0.60
10.44%
-0.31
48.00%
capex to depreciation
-25.67
-
-17.90
30.26%
-6.63
62.97%
-1.96
70.42%
-10.97
459.73%
-7.96
27.43%
-7.41
6.97%
-9.72
31.26%
-9.94
2.24%
-6.43
35.31%
-2.61
59.44%
capex to operating cash flow
-0.47
-
-0.47
1.17%
-0.30
36.06%
-0.16
46.40%
-0.58
264.35%
-0.45
22.70%
-0.38
16.29%
-0.37
1.38%
-0.43
15.33%
-0.54
25.18%
-0.27
49.91%
capex to revenue
-0.21
-
-0.17
16.67%
-0.12
30.38%
-0.05
56.31%
-0.25
369.30%
-0.17
30.99%
-0.15
9.72%
-0.18
18.78%
-0.20
9.73%
-0.19
4.91%
-0.13
32.66%
cash per share
0.35
-
0.33
6.07%
0.41
23.80%
1.03
152.48%
1.36
31.71%
1.37
0.94%
1.59
15.86%
1.95
23.24%
3.07
57.35%
3.22
4.79%
3.42
6.20%
days of inventory on hand
201.15
-
225.84
12.27%
181.10
19.81%
210.97
16.50%
144.93
31.30%
144.54
0.27%
170.70
18.10%
152.96
10.39%
178.43
16.65%
289.55
62.28%
365.96
26.39%
days payables outstanding
43.39
-
63.03
45.27%
131.87
109.22%
83.37
36.78%
82.16
1.44%
70.66
14.00%
60.71
14.08%
63.65
4.85%
55.16
13.34%
106.59
93.24%
128.92
20.95%
days sales outstanding
29.90
-
42.57
42.37%
53.11
24.76%
59.51
12.06%
63.05
5.96%
58.29
7.56%
49.51
15.06%
51.63
4.30%
51.50
0.26%
51.23
0.52%
18.85
63.20%
debt to assets
0.19
-
0.24
23.56%
0.30
28.19%
debt to equity
0.27
-
0.36
30.68%
0.53
49.07%
dividend yield
0.01
-
0.02
134.43%
0.02
1.47%
0.01
-
0.01
33.00%
0.01
5.67%
0.01
16.39%
0.01
77.16%
0.03
139.08%
0.03
7.38%
earnings yield
0.02
-
0.03
26.47%
0.03
25.58%
0.01
68.18%
0.02
106.18%
0.02
7.16%
0.02
22.00%
0.02
14.82%
0.03
72.36%
0.04
29.37%
0.02
31.59%
enterprise value
5.55B
-
5.55B
0.09%
5.48B
1.27%
17.53B
219.66%
11.42B
34.85%
15.38B
34.68%
28.70B
86.59%
52.39B
82.50%
41.41B
20.95%
23.31B
43.70%
16.51B
29.20%
enterprise value over ebitda
38.66
-
31.58
18.31%
23.04
27.04%
67.77
194.09%
36.77
45.74%
30.98
15.75%
40.84
31.81%
49.77
21.88%
28.06
43.62%
20.62
26.51%
24.15
17.13%
ev to operating cash flow
41.63
-
40.44
2.85%
26.73
33.91%
98.14
267.16%
37.56
61.73%
40.05
6.64%
49.19
22.82%
54.71
11.22%
33.14
39.42%
26.38
20.41%
18.01
31.74%
ev to sales
18.28
-
14.98
18.09%
10.78
28.04%
32.25
199.24%
15.90
50.70%
15.13
4.80%
20.05
32.47%
26.85
33.95%
15.48
42.36%
9.36
39.54%
8.59
8.24%
free cash flow per share
0.10
-
0.10
4.30%
0.20
97.32%
0.20
0.38%
0.16
20.55%
0.27
65.73%
0.46
71.14%
0.75
64.88%
0.89
17.48%
0.51
42.06%
0.84
64.25%
free cash flow yield
0.01
-
0.01
4.30%
0.02
97.32%
0.01
67.08%
0.01
23.45%
0.01
26.33%
0.01
5.35%
0.01
8.08%
0.02
49.48%
0.02
0.28%
0.04
128.83%
graham net net
0.28
-
0.28
1.23%
0.34
21.57%
1.00
195.42%
1.11
11.01%
1.14
3.28%
1.42
24.14%
1.81
27.49%
1.77
1.94%
1.48
16.74%
0.75
49.48%
graham number
1.47
-
1.80
22.80%
2.26
25.30%
3.14
38.94%
3.81
21.25%
4.98
30.66%
6.62
32.92%
9.34
41.22%
11.84
26.72%
10.65
10.06%
7.01
34.22%
income quality
1.05
-
0.86
18.39%
1.02
19.28%
0.88
13.66%
1.07
20.96%
0.96
10.40%
1.03
7.11%
1.10
6.90%
1.04
4.74%
1.00
3.97%
2.15
114.64%
intangibles to total assets
0.05
-
0.04
12.18%
0.04
19.25%
0.02
47.74%
0.03
53.73%
0.04
54.66%
0.04
16.42%
0.04
12.78%
0.03
27.42%
0.03
15.51%
0.02
20.48%
interest coverage
159.16
-
28.56
82.06%
10.01
64.96%
interest debt per share
1.15
-
1.65
43.22%
2.18
31.90%
inventory turnover
1.81
-
1.62
10.93%
2.02
24.71%
1.73
14.16%
2.52
45.57%
2.53
0.27%
2.14
15.32%
2.39
11.60%
2.05
14.28%
1.26
38.38%
1.00
20.88%
invested capital
0.27
-
0.36
30.68%
0.53
49.07%
market cap
5.80B
-
5.79B
0.19%
5.77B
0.27%
18.29B
216.91%
12.48B
31.75%
16.46B
31.89%
29.98B
82.07%
53.96B
80.02%
42.81B
20.66%
24.60B
42.55%
17.64B
28.28%
net current asset value
218.32M
-
224.33M
2.75%
275.57M
22.84%
883.39M
220.56%
919.76M
4.12%
975.20M
6.03%
1.24B
26.70%
1.60B
29.78%
1.63B
1.60%
1.47B
9.75%
921.41M
37.33%
net debt to ebitda
-1.73
-
-1.32
23.48%
-1.21
8.76%
-2.94
143.24%
-3.42
16.33%
-2.18
36.32%
-1.81
16.88%
-1.50
17.29%
-0.95
36.51%
-1.13
19.44%
-1.66
46.42%
net income per share
0.18
-
0.23
26.47%
0.28
25.58%
0.27
3.70%
0.36
32.69%
0.51
40.58%
0.72
41.03%
1.10
52.78%
1.49
35.45%
1.12
24.83%
0.55
50.89%
operating cash flow per share
0.19
-
0.19
3.21%
0.29
49.79%
0.24
16.86%
0.39
60.53%
0.49
25.63%
0.74
50.88%
1.20
63.50%
1.56
29.26%
1.11
28.46%
1.16
3.81%
payables turnover
8.41
-
5.79
31.16%
2.77
52.20%
4.38
58.18%
4.44
1.46%
5.17
16.28%
6.01
16.39%
5.73
4.62%
6.62
15.40%
3.42
48.25%
2.83
17.32%
receivables turnover
12.21
-
8.57
29.76%
6.87
19.84%
6.13
10.76%
5.79
5.62%
6.26
8.18%
7.37
17.74%
7.07
4.12%
7.09
0.26%
7.12
0.52%
19.36
171.75%
research and ddevelopement to revenue
0.03
-
0.04
25.86%
0.03
16.23%
0.04
17.20%
0.04
7.45%
0.05
22.46%
0.05
5.33%
0.04
13.41%
0.06
56.89%
0.10
56.91%
0.13
25.25%
return on tangible assets
0.29
-
0.31
7.45%
0.30
2.84%
0.16
47.50%
0.17
8.55%
0.20
19.17%
0.24
15.92%
0.28
19.50%
0.26
9.63%
0.17
34.28%
0.08
52.34%
revenue per share
0.43
-
0.52
22.41%
0.72
37.57%
0.74
2.02%
0.92
24.63%
1.29
40.72%
1.81
39.89%
2.45
35.75%
3.33
35.86%
3.14
5.82%
2.42
22.78%
roe
0.33
-
0.35
6.06%
0.36
0.45%
0.17
51.96%
0.20
19.77%
0.24
15.76%
0.27
12.58%
0.31
17.04%
0.36
14.27%
0.25
30.15%
0.14
44.28%
roic
0.32
-
0.32
1.12%
0.34
6.72%
0.17
51.93%
0.20
20.66%
0.24
19.17%
0.27
13.20%
0.32
18.13%
0.28
11.69%
0.18
34.71%
0.09
49.71%
sales general and administrative to revenue
0.02
-
0.02
7.68%
0.03
4.78%
0.03
15.29%
0.02
24.32%
0.02
0.36%
0.02
12.76%
0.01
34.04%
0.01
10.13%
0.01
11.56%
0.03
94.05%
shareholders equity per share
0.54
-
0.64
19.24%
0.80
25.02%
1.60
100.46%
1.78
10.79%
2.16
21.44%
2.70
25.28%
3.53
30.54%
4.18
18.54%
4.50
7.62%
3.97
11.87%
stock based compensation to revenue
tangible asset value
356.98M
-
428.69M
20.09%
539.58M
25.87%
1.16B
114.96%
1.34B
15.77%
1.63B
21.48%
2.08B
27.41%
2.70B
29.89%
3.24B
19.95%
3.45B
6.61%
3.04B
11.93%
tangible book value per share
0.50
-
0.61
20.31%
0.77
26.21%
1.57
105.28%
1.71
9.17%
2.07
20.83%
2.62
26.54%
3.39
29.42%
4.03
18.82%
4.35
7.81%
3.83
11.86%
working capital
246.63M
-
257.30M
4.33%
311.03M
20.88%
914.91M
194.16%
960.82M
5.02%
1.03B
6.82%
1.30B
26.38%
1.66B
27.65%
2.67B
61.22%
2.58B
3.50%
2.48B
3.64%

All numbers in (except ratios and percentages)